Business
China Resources Sanjiu Medical & Pharmaceutical Co: Revenue up 18.62% but net profit down 15.29% as costs and investments surged
China Resources Sanjiu Medical & Pharmaceutical Co: Revenue up 18.62% but net profit down 15.29% as costs and investments surged
About this update from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A
Q1 2026 revenue grew 18.62% year-over-year, but net profit fell 15.29% due to sharply higher sales and R&D expenses. Operating cash flow improved, while cash reserves declined as debt repayments increased and government subsidies dropped.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.